Rua Bioscience Limited (RUA.NZ)
Rua Bioscience Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Gisborne, GI, NZ. The stock last traded at $0.03, down 0.00% on the session, giving a market capitalisation of $8.8M. Its beta of 0.48 implies it has historically moved less than the broad market.
Rua Bioscience Limited, a company founded in 2016 and headquartered in Gisborne, New Zealand, is dedicated to the investigation, refinement, and production of medicinal products for both the New Zealand market and international distribution. Their offerings primarily include pharmaceuticals developed from cannabinoids. The firm officially changed its name to Rua Bioscience Limited in October 2019, having previously been known as Hikurangi Cannabis Company Limited.